N/A N=61 Randomized Single-blind Prevention

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

Nicotine Dependence · Nicotine Addiction · Nicotine Use Disorder · Nicotine Vaping · Vaping

Bottom Line

View on ClinicalTrials.gov: NCT05897242 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2025

Primary outcome: Primary: Overall Treatment Satisfaction Rating — 3.8 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Smartphone app (Behavioral); Text Message (Other); Survey Administration (Other)
Age: Adult · 18+ yrs
Sex: All
Sponsor: Fred Hutchinson Cancer Center
Primary completion: Apr 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Overall Treatment Satisfaction Rating	3.8	—
PRIMARY Change in Readiness to Quit	0.96; 0.72	—
PRIMARY Percentage of Participants With a 24-hour Quit Attempt	21; 22	—
PRIMARY Cotinine-confirmed 30-day Point Prevalence Abstinence From All Nicotine and Tobacco	1; 0	—

Summary

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Eligibility Criteria

Inclusion Criteria

Age 18-30.
Current weekly user of e-cigarette product(s).
Owns an Android phone or iPhone.
Has an email address.
United States (US) resident, with a US mailing address.
Willing to complete all study procedures.

Exclusion Criteria

Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatments is allowable during trial participation).
Member of the same household as another research participant.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05897242). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.